Filing Details
- Accession Number:
- 0001708138-20-000108
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-18 16:02:15
- Reporting Period:
- 2020-11-16
- Accepted Time:
- 2020-11-18 16:02:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1796226 | J Andrew Murphy | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Research | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-16 | 13,736 | $30.63 | 60,872 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-16 | 7,108 | $561.39 | 53,764 | No | 4 | F | Direct | |
Common Stock | Disposition | 2020-11-17 | 743 | $536.68 | 53,021 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 229 | $537.38 | 52,792 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 591 | $538.37 | 52,201 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 42 | $539.87 | 52,159 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 1,442 | $540.49 | 50,717 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 812 | $541.42 | 49,905 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 294 | $542.37 | 49,611 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 467 | $543.65 | 49,144 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 68 | $544.01 | 49,076 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 171 | $545.47 | 48,905 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 524 | $546.61 | 48,381 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 148 | $547.12 | 48,233 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 216 | $548.77 | 48,017 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 283 | $549.67 | 47,734 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 206 | $550.71 | 47,528 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 141 | $551.48 | 47,387 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 73 | $552.88 | 47,314 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 64 | $553.21 | 47,250 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-11-17 | 114 | $556.45 | 47,136 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-11-16 | 13,736 | $0.00 | 13,736 | $30.63 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2020-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,242 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 743 shares of Company stock on November 17, 2020 at prices ranging from $536.41 to $536.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 229 shares of Company stock on November 17, 2020 at prices ranging from $537.15 to $537.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 591 shares of Company stock on November 17, 2020 at prices ranging from $538.03 to $538.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 42 shares of Company stock on November 17, 2020 at prices ranging from $539.50 to $539.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 1,442 shares of Company stock on November 17, 2020 at prices ranging from $540.00 to $540.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 812 shares of Company stock on November 17, 2020 at prices ranging from $541.01 to $541.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 294 shares of Company stock on November 17, 2020 at prices ranging from $542.15 to $542.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 467 shares of Company stock on November 17, 2020 at prices ranging from $543.07 to $543.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 171 shares of Company stock on November 17, 2020 at prices ranging from $545.37 to $545.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 524 shares of Company stock on November 17, 2020 at prices ranging from $546.08 to $546.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 148 shares of Company stock on November 17, 2020 at prices ranging from $547.12 to $547.20. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 216 shares of Company stock on November 17, 2020 at prices ranging from $548.47 to $548.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 283 shares of Company stock on November 17, 2020 at prices ranging from $549.03 to $549.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 206 shares of Company stock on November 17, 2020 at prices ranging from $550.52 to $550.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 141 shares of Company stock on November 17, 2020 at prices ranging from $551.31 to $551.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 114 shares of Company stock on November 17, 2020 at prices ranging from $556.38 to $556.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.